Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality

J Exp Med. 1994 Oct 1;180(4):1571-5. doi: 10.1084/jem.180.4.1571.

Abstract

We here report that alpha 1-acid glycoprotein, a typical acute phase protein, protects mice from lethal shock induced by tumor necrosis factor (TNF) or endotoxin. The protection is observed both in normal and in galactosamine-sensitized mice. Optimal desensitization requires at least 3 mg alpha 1-acid glycoprotein administered 2 h before the lethal challenge. Under these conditions, complete inhibition of all TNF-induced metabolic changes was observed: fall in body temperature, release of liver transaminases, enhanced clotting time, and mortality. The known platelet aggregation-inhibitory activity of alpha 1-acid glycoprotein provides a possible explanation for this protective capacity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Galactosamine / toxicity
  • Lipopolysaccharides / toxicity
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred C57BL
  • Orosomucoid / pharmacology*
  • Tumor Necrosis Factor-alpha / toxicity*

Substances

  • Lipopolysaccharides
  • Orosomucoid
  • Tumor Necrosis Factor-alpha
  • Galactosamine